# Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva

> **NCT04578509** · — · COMPLETED · sponsor: **Assistance Publique - Hôpitaux de Paris** · enrollment: 5197 (actual)

## Conditions studied

- SARS-CoV-2 Infection
- COVID-19

## Interventions

- **DIAGNOSTIC_TEST:** Nasopharyngeal swab
- **DIAGNOSTIC_TEST:** Saliva sample
- **DIAGNOSTIC_TEST:** axillary sweat sample
- **OTHER:** Data collection

## Key facts

- **NCT ID:** NCT04578509
- **Lead sponsor:** Assistance Publique - Hôpitaux de Paris
- **Sponsor class:** OTHER
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** COMPLETED
- **Start date:** 2020-10-19
- **Primary completion:** 2021-06-09
- **Final completion:** 2021-06-09
- **Target enrollment:** 5197 (ACTUAL)
- **Last updated:** 2026-03-09

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04578509

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04578509, "Evaluation of a Screening Program for SARS-CoV-2 Infection in the General Population Based on the Use of New Detection Approaches or for Diagnostic Orientation on Saliva". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT04578509. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*